National surveillance of dialysis associated diseases in the United States--1994.

Dialysis centers in the United States were surveyed in 1994 regarding a number of hemodialysis associated diseases and practices. A total of 2,449 centers, representing 206,884 patients and 50,314 staff members, responded. In 1994, 99% of centers used bicarbonate dialysate as the primary method of dialysis, 45% used high flux dialysis, and 75% reused dialyzers. Hepatitis B vaccine had been administered to 31% of patients and to 80% of staff members. Acute infection with hepatitis B virus occurred in 0.1% of patients and was more likely to be reported by centers with lower proportions of patients vaccinated against hepatitis B virus and those not using a separate room and dialysis machine to treat hepatitis B surface antigen positive patients. The prevalence of antibody to hepatitis C virus was 10.5% among patients and 1.9% among staff members and varied according to geographic region. Pyrogenic reactions in the absence of septicemia were reported by 22% of centers and were most highly associated with dialyzer reuse. Human immunodeficiency virus infection was reported to be present in 1.5% of patients; 37% of centers provided hemodialysis to one or more patients infected with human immunodeficiency virus.

[1]  M. Alter,et al.  National surveillance of dialysis associated diseases in the United States, 1995. , 1998, ASAIO journal.

[2]  M. Alter,et al.  National surveillance of dialysis associated diseases in the United States, 1993. , 1996, ASAIO journal.

[3]  M. Alter,et al.  National surveillance of dialysis associated diseases in the United States, 1992. , 1994, ASAIO journal.

[4]  M. Alter,et al.  National surveillance of dialysis associated diseases in the United States, 1991. , 1993, ASAIO journal.

[5]  M. Alter,et al.  National surveillance of hemodialysis associated diseases in the United States, 1990. , 1993, ASAIO journal.

[6]  M. Alter,et al.  National surveillance of dialysis-associated diseases in the United States, 1989. , 1991, ASAIO transactions.

[7]  M. Alter,et al.  National Surveillance of Dialysis‐Associated Diseases in the United States, 1988 , 1990, ASAIO transactions.

[8]  M. Alter,et al.  National surveillance of dialysis associated diseases in the United States--1994. , 1997, ASAIO journal.

[9]  M. Alter,et al.  Hemodialysis-associated hepatitis B: report of an outbreak , 1989 .

[10]  M. Alter,et al.  Hepatitis B virus transmission associated with a multiple-dose vial in a hemodialysis unit. , 1983, Annals of internal medicine.

[11]  M. Alter,et al.  National surveillance of dialysis-associated hepatitis and other diseases. 1976 and 1980 , 1983 .

[12]  D. Snydman,et al.  Hemodialysis-Associated Hepatitis in the United States, 1974 , 1977 .

[13]  J. Guàrdia,et al.  [Hepatitis B in a hemodialysis unit]. , 1976, Revista clinica espanola.